The relationship between angiotensin-converting enzyme insertion/deletion polymorphism and proliferative retinopathy in type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 81, Issue 3, 2008, Pages

  Feghhi, Mostafa ^a   Nikzamir, Abdolrahim ^a   Esteghamati, Alireza ^b   Farahi, Fereidoon ^a   Nakhjavani, Manouchehr ^b   Rashidi, Armin ^b  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ACE; Polymorphism; Proliferative; Retinopathy; Type 2 diabetes

Indexed keywords

ANTIHYPERTENSIVE AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DNA POLYMORPHISM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROLIFERATIVE RETINOPATHY; RISK ASSESSMENT;

AGED; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTAGENESIS, INSERTIONAL; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; SEQUENCE DELETION;

EID: 48949095932     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.04.021     Document Type: Article

References (21)

1. Dodson P.M. Diabetic retinopathy: treatment and prevention. Diab. Vasc. Dis. Res. 4 (2007) 9-11
2. Aiello L.P., Gardner T.W., King G.L., Blankenship G., Cavallerano J.D., Ferris F.L., et al. Diabetic retinopathy. Diabetes Care 21 (1998) 143-156
3. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
4. Mancia G., De Backer G., Dominiczak A., et al. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 25 (2007) 1105-1187
5. Nakhjavani M., Esfahanian F., Jahanshahi A., Esteghamati A., Nikzamir A.R., Rashidi A., et al. The relationship between the insertion/deletion polymorphism of the ACE gene and hypertension in Iranian patients with type 2 diabetes. Nephrol. Dial. Transpl. 22 (2007) 2549-2553
6. Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am. J. Med. 59 (1975) 365-372
7. Liao L., Lei M.X., Chen H.L., Guo L.J., and Han X.Y. Angiotensin converting enzyme gene polymorphism and type 2 diabetic retinopathy. Zhong Nan Da Xue Xue Bao Yi Xue Ban 29 (2004) 410-413
8. Wu S.S., Guo Q.M., Liu G.L., Zhang J., Zhao C.F., Ning S.C., et al. The relationship of angiotensin I-converting enzyme gene polymorphism with diabetic retinopathy and diabetes myocardial infarction. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 21 (2004) 283-285
9. Globocnik-Petrovic M., Hawlina M., Peterlin B., and Petrovic D. Insertion/deletion plasminogen activator inhibitor 1 and insertion/deletion angiotensin-converting enzyme gene polymorphisms in diabetic retinopathy in type 2 diabetes. Ophthalmologica 217 (2003) 219-224
10. Liao L., Lei M., Chen H., Han X., and Fan C. Studies on ACE gene insertion/deletion polymorphism, serum ACE activity, and diabetic retinopathy in type II diabetic patients. Hunan Yi Ke Da Xue Xue Bao 24 (1999) 33-36
11. Matsumoto A., Iwashima Y., Abiko A., Morikawa A., Sekiguchi M., Eto M., et al. Detection of the association between a deletion polymorphism in the gene encoding angiotensin I-converting enzyme and advanced diabetic retinopathy. Diabetes Res. Clin. Pract. 50 (2000) 195-202
12. Fujisawa T., Ikegami H., Kawaguchi Y., Hamada Y., Ueda H., Shintani M., et al. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 41 (1998) 47-53
13. Gutiérrez C., Vendrell J., Pastor R., Llor C., Aguilar C., Broch M., et al. Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms in non-insulin-dependent diabetes mellitus. Lack of relationship with diabetic nephropathy and retinopathy in a Caucasian Mediterranean population. Metabolism 46 (1997) 976-980
14. Fujisawa T., Ikegami H., Shen G.Q., Yamato E., Takekawa K., Nakagawa Y., et al. Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 18 (1995) 983-985
15. Marre M., Bernadet P., Gallois Y., Savagner F., Guyene T.T., Hallab M., et al. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43 (1994) 348-384
16. Nagi D.K., Mansfield M.W., Stickland M.H., and Grant P.J. Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism, and diabetic retinopathy in subjects with IDDM and NIDDM. Diabetic Med. 12 (1995) 997-1001
17. Jacobsen P.K., Tarnow L., and Parving H.H. Time to consider ACE insertion/deletion genotypes and individual renoprotective treatment in diabetic nephropathy?. Kidney Int. 69 (2006) 1293-1295
18. O'Donnell C.J., Lindpaintner K., Larson M.G., Rao V.S., Ordovas J.M., Schaefer E.J., et al. Evidence for association and genetic linkage of the angiotensin converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 97 (1998) 1766-1772
19. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., and Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86 (1990) 1343-1346
20. Neroev V.V., Chesnokova N.B., Okhotsimskaia T.D., Riabina M.V., Kost O.A., Nikol'skaia I.I., et al. Activity of angiotensin-converting enzyme in the blood and tear of patients with diabetic retinopathy. Vestn. Oftalmol. 122 (2006) 11-14
21. Ishizaki E., Takai S., Ueki M., Maeno T., Maruichi M., Sugiyama T., et al. Correlation between angiotensin-converting enzyme, vascular endothelial growth factor, and matrix metalloproteinase-9 in the vitreous of eyes with diabetic retinopathy. Am. J. Ophthalmol. 141 (2006) 129-134